Armata Pharma’s Executive Option Grants Boost Confidence in Phage‑Therapy Pipeline
Armata Pharmaceuticals’ new executive option grants show strong confidence in its phage‑therapy pipeline, offering insight into leadership alignment and potential upside as the company advances toward FDA approval.
4 minutes to read